Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex
NCT ID: NCT02401841
Last Updated: 2015-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sugammadex and Neostigmine at Shallow Neuromuscular Blockade
NCT00895609
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
NCT03346070
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients
NCT06228092
The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal
NCT03579589
Effect of Neuromuscular Blockade and Reversal on Breathing
NCT02845375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugammadex
Patients treated with Sugammadex
Two different types of drug for resolution of neuro-muscular blockade
Neostigmine
Patients treated with Neostigmine
Two different types of drug for resolution of neuro-muscular blockade
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Two different types of drug for resolution of neuro-muscular blockade
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Videolaparoscopic surgery
Exclusion Criteria
* No acceptation of informed consent
* New York Heart Association \> 2
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Policlinico Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davide Chiumello
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione IRCC Ca' Granda - Ospedale Maggiore Policlinico
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Policlinico 12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.